These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16272753)
1. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A. Emoto C; Murase S; Sawada Y; Iwasaki K Drug Metab Pharmacokinet; 2005 Oct; 20(5):351-7. PubMed ID: 16272753 [TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole. Emoto C; Murase S; Sawada Y; Jones BC; Iwasaki K Drug Metab Pharmacokinet; 2003; 18(5):287-95. PubMed ID: 15618748 [TBL] [Abstract][Full Text] [Related]
3. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
4. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Wen X; Wang JS; Neuvonen PJ; Backman JT Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802 [TBL] [Abstract][Full Text] [Related]
5. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study. Li Z; Zhang Y; Gao Y; Xiang Y; Zhang W; Lu C; Zhuang X Eur J Pharm Sci; 2019 Mar; 130():156-165. PubMed ID: 30690186 [TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9. Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509 [TBL] [Abstract][Full Text] [Related]
7. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063 [TBL] [Abstract][Full Text] [Related]
9. Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes. Dalmadi B; Leibinger J; Szeberényi S; Borbás T; Farkas S; Szombathelyi Z; Tihanyi K Drug Metab Dispos; 2003 May; 31(5):631-6. PubMed ID: 12695352 [TBL] [Abstract][Full Text] [Related]
10. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans. Echizen H; Tanizaki M; Tatsuno J; Chiba K; Berwick T; Tani M; Gonzalez FJ; Ishizaki T Drug Metab Dispos; 2000 Aug; 28(8):937-44. PubMed ID: 10901704 [TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes. Yao HT; Chang YW; Lan SJ; Yeh TK Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human drug metabolizing cytochrome P450 by buprenorphine. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2002 May; 25(5):682-5. PubMed ID: 12033517 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes. Kim JH; Kwon SS; Jeong HU; Lee HS Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes). Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472 [TBL] [Abstract][Full Text] [Related]
15. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Yoshimoto K; Echizen H; Chiba K; Tani M; Ishizaki T Br J Clin Pharmacol; 1995 Apr; 39(4):421-31. PubMed ID: 7640150 [TBL] [Abstract][Full Text] [Related]
16. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760 [TBL] [Abstract][Full Text] [Related]
17. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. Zhao K; Ding M; Cao H; Cao ZX J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175 [TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661 [TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Lu P; Schrag ML; Slaughter DE; Raab CE; Shou M; Rodrigues AD Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767 [TBL] [Abstract][Full Text] [Related]
20. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Niwa T; Inoue S; Shiraga T; Takagi A Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]